[Form 4] Watts Water Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 quick take: On 07/28/2025, Performant Healthcare (PHLT) director James LaCamp reported the grant of 35,616 restricted stock units (RSUs) at no cost. Each unit converts to one common share.

Vesting: 100 % of the RSUs vest on the earlier of the company’s 2026 annual shareholder meeting or a Change in Control, as specified in the Amended & Restated 2012 Stock Incentive Plan. Settlement is stock-for-stock, with no cash component.

Post-grant ownership: LaCamp now holds 35,616 derivative securities directly; no sales or open-market purchases of common stock were disclosed in Table I. The filing represents routine director compensation, carries no immediate dilution, and is unlikely to have a material market impact.

Insights

Securities Analyst

TL;DR: Routine RSU grant; no buy/sell; neutral impact.

The 35,616-share RSU award aligns the director’s incentives with shareholders but does not inject cash or signal trading intent. Because the grant vests over a standard governance milestone and equals a modest ownership stake, it is unlikely to influence valuation or liquidity. Investors may view continued insider equity accrual positively, yet the absence of purchases limits bullish interpretation. Overall, the disclosure is compliance-related and neutral for the investment thesis.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lada Ryan

(Last) (First) (Middle)

815 CHESTNUT STREET

(Street)

NORTH ANDOVER MA 01845

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WATTS WATER TECHNOLOGIES INC [ WTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/28/2025		A		1,982(1)	A	$0.0000	1,982	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of shares of deferred stock that vest in three equal annual installments beginning on the first anniversary of the date of grant.

	/s/ Seth M. Kipp, Attorney-in-Fact	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.